Expression of MiR-34a-5p is Up-regulated in Human Colorectal Cancer and Correlates with Survival and Clock Gene PER2 Expression

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Oct 29

PMID 31658284

Citations 30

Authors

Kristina Hasakova

Richard Reis

Marian Vician

Michal Zeman

Iveta Herichova

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer represents a leading cause of cancer death. MicroRNAs (miRNAs) are small non-coding RNA molecules that have been extensively studied in tumours, since changes in their levels can reveal patient prognosis. Cancer progression is also influenced by the circadian system whose functioning is based on the rhythmic expression of clock genes. Therefore, we performed macroarray screening of tumour and adjacent tissues in patients undergoing surgery for colorectal carcinoma. We identified 17 miRNAs showing expression that was more than 100 times higher in tumour tissue compared to adjacent tissue. From in silico analysis, miR-34a-5p was selected as showing a computer-predicted interaction with PER2. Real-time PCR revealed a negative correlation between expression of PER2 mRNA and miR-34a in patients with more advanced cancer stage. Expression of miR-34a was up-regulated in cancer tissue compared to adjacent tissue. High miR-34a expression was associated with better survival of patients. miR-34a showed lower expression levels in male patients with lymph node involvement, and a trend towards decreased expression in male patients with distant metastases. Male patients, but not female patients, with high expression of miR-34a and who were free of distant metastases and/or lymph node involvement showed better survival. Therefore, we proposed that expression of miR-34a was regulated in a sex-dependent manner and could be considered a marker of prognosis in earlier cancer stages in male patients.

Citing Articles

The role of miR-16 and miR-34a family in the regulation of cancers: A review.

Sadeghi Z, Malekzadeh M, Sharifi M, Hashemibeni B Heliyon. 2025; 11(4):e42733.

PMID: 40061926 PMC: 11889592. DOI: 10.1016/j.heliyon.2025.e42733.

The Circadian Clock as a Potential Biomarker and Therapeutic Target in Gastrointestinal Cancers.

Barati S, Saffar H, Mehrabadi S, Avan A Curr Pharm Des. 2024; 30(23):1804-1811.

PMID: 38798218 DOI: 10.2174/0113816128302762240515054444.

Impact of Long-Lasting Environmental Factors on Regulation Mediated by the miR-34 Family.

Stefanik P, Morova M, Herichova I Biomedicines. 2024; 12(2).

PMID: 38398026 PMC: 10887245. DOI: 10.3390/biomedicines12020424.

microRNAs Regulate Survivin in Colorectal Cancer Patients.

Chavoshi H, Bornehdeli S, Asadi M, Dolatkhah R, Caner A, Raeisi M Adv Biomed Res. 2023; 12:227.

PMID: 38073748 PMC: 10699232. DOI: 10.4103/abr.abr_233_22.

Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.

Moravcik R, Olejarova S, Zlacka J, Herichova I PLoS One. 2023; 18(10):e0292880.

PMID: 37831728 PMC: 10575541. DOI: 10.1371/journal.pone.0292880.

References

Balakrishnan A, Stearns A, Park P, Dreyfuss J, Ashley S, Rhoads D . MicroRNA mir-16 is anti-proliferative in enterocytes and exhibits diurnal rhythmicity in intestinal crypts. Exp Cell Res. 2010; 316(20):3512-21. PMC: 2976799. DOI: 10.1016/j.yexcr.2010.07.007. View

Xu S, Witmer P, Lumayag S, Kovacs B, Valle D . MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem. 2007; 282(34):25053-66. DOI: 10.1074/jbc.M700501200. View

Ko C, Takahashi J . Molecular components of the mammalian circadian clock. Hum Mol Genet. 2006; 15 Spec No 2:R271-7. DOI: 10.1093/hmg/ddl207. View

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

Cheng H, Papp J, Varlamova O, Dziema H, Russell B, Curfman J . microRNA modulation of circadian-clock period and entrainment. Neuron. 2007; 54(5):813-29. PMC: 2590749. DOI: 10.1016/j.neuron.2007.05.017. View

Rapti S, Kontos C, Christodoulou S, Papadopoulos I, Scorilas A . miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. Clin Biochem. 2017; 50(16-17):918-924. DOI: 10.1016/j.clinbiochem.2017.06.004. View

Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y . Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008; 68(11):4123-32. DOI: 10.1158/0008-5472.CAN-08-0325. View

Siemens H, Neumann J, Jackstadt R, Mansmann U, Horst D, Kirchner T . Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer. Clin Cancer Res. 2012; 19(3):710-20. DOI: 10.1158/1078-0432.CCR-12-1703. View

Gatfield D, Le Martelot G, Vejnar C, Gerlach D, Schaad O, Fleury-Olela F . Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 2009; 23(11):1313-26. PMC: 2701584. DOI: 10.1101/gad.1781009. View

10.

Michael M, O Connor S, van Holst Pellekaan N, Young G, James R . Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003; 1(12):882-91. View

11.

Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N . Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006; 5:29. PMC: 1550420. DOI: 10.1186/1476-4598-5-29. View

12.

Koturbash I, Zemp F, Kutanzi K, Luzhna L, Loree J, Kolb B . Sex-specific microRNAome deregulation in the shielded bystander spleen of cranially exposed mice. Cell Cycle. 2008; 7(11):1658-67. DOI: 10.4161/cc.7.11.5981. View

13.

Zeman M, Vician M, Monosikova J, Reis R, Herichova I . Deregulated expression of the per2 gene in human colorectal carcinoma. Mol Med Rep. 2011; 1(4):599-603. View

14.

Papantoniou K, Devore E, Massa J, Strohmaier S, Vetter C, Yang L . Rotating night shift work and colorectal cancer risk in the nurses' health studies. Int J Cancer. 2018; 143(11):2709-2717. PMC: 6235706. DOI: 10.1002/ijc.31655. View

15.

Masuda T, Hayashi N, Kuroda Y, Ito S, Eguchi H, Mimori K . MicroRNAs as Biomarkers in Colorectal Cancer. Cancers (Basel). 2017; 9(9). PMC: 5615339. DOI: 10.3390/cancers9090124. View

16.

Zhang X, Ai F, Li X, Tian L, Wang X, Shen S . MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling. Oncol Lett. 2017; 14(2):2325-2333. PMC: 5530141. DOI: 10.3892/ol.2017.6444. View

17.

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

18.

Arndt G, Dossey L, Cullen L, Lai A, Druker R, Eisbacher M . Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 2009; 9:374. PMC: 2770572. DOI: 10.1186/1471-2407-9-374. View

19.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M . Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2008; 72(5-6):397-402. DOI: 10.1159/000113489. View

20.

Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C . Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 2006; 97(7):589-96. PMC: 2662332. DOI: 10.1111/j.1349-7006.2006.00225.x. View